Pipetting in Lab (IMAGE)

Entos Pharmaceuticals

Pipetting in Lab

Caption

Entos is developing Covigenix, a pan-coronavirus DNA vaccine based on its Fusogenix drug delivery technology. EpiVax will provide optimized epitopes from multiple COVID-19 proteins identified using their proprietary in silico immunogenicity screening technology.

Credit

TEC Edmonton

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.